ReviewJOR spine2026
My Love Story With HIFs in the Disc: A Journey to the Humboldt Research Award.
Review in JOR spine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
The intervertebral disc is a prime example of tissue adaptation to metabolic and mechanical extremes. As the largest avascular organ in the human body, the disc and the central nucleus pulposus (NP) endure constant compressive loading while sustaining a hypoxic, relatively acidic, and hyperosmotic microenvironment that would be inhospitable to most cell types. Over the past two decades, work from my laboratory has revealed extraordinary details of this type of adaptation, that hypoxia-inducible factors (HIFs), particularly HIF-1α, serve as master regulators of NP cell survival, metabolism, and matrix homeostasis. This review chronicles the scientific and personal journey that began with a single unexpected observation: the normoxic stabilization of HIF-1α in NP cells. That finding grew into a substantial understanding of oxygen-independent HIF regulation and biology in the disc. Through sustained collaborations with Irving Shapiro and other colleagues and a succession of talented trainees, we demonstrated that HIF-1α is indispensable for disc development and homeostasis. In contrast, HIF-2α plays a distinct, largely opposing role, promoting matrix catabolism and fibrosis. Our work has revealed the molecular architecture underlying the disc's adaptation to avascularity, encompassing HIF-dependent regulation of glycolytic enzymes, glucose transporters, carbonic anhydrases CA9 and CA12, monocarboxylate transporter 4 (MCT4), and BNIP3-mediated mitophagy, and has opened promising therapeutic avenues for disc regeneration. Recently, we discovered that NP-derived lactate exported via MCT4 is actively imported primarily by vertebral endplate cells, and, to a lesser extent, by annulus fibrosus cells via MCT1, where it serves dual roles as a TCA metabolite and an epigenetic regulator through lactylation. This review celebrates the intellectual journey, the collaborative spirit that sustained it, and the honor of the Alexander von Humboldt Research Award, while providing a synthesis of HIF biology in the intervertebral disc spanning the discovery of oxygen by Priestley 1774 to the 2019 Nobel Prize and beyond.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.